After seven years of sparring, Novartis (NVS) has agreed to pay $678 million to settle a lawsuit in which the federal government alleged the drug maker used kickbacks to doctors — including fishing trips and lavish restaurant meals — in order to boost prescriptions of several medicines.

The settlement ends a long-running battle that began in 2011, when a former Novartis sales rep named Oswald Bilotta filed a whistleblower lawsuit claiming the company ran so-called speaker programs that were actually blatant marketing tools, rather than educational sessions for doctors. And as a result of the bribes, the drug maker caused federal health care programs to overpay for medicines.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy